Personalized Genomics to Drive the Smart Pills Market

The Smart Pills Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks.

Integration of smart technologies in pills has instrumented a ground-breaking transformation in the global healthcare marketplace. Initially, consumers and patients were diffident towards invasive surgical procedures and drug administration, albeit, their perspectives have undergone changes. There is a growing uptake for indigestible medical devices, which has propelled the consumption of smart pills. Elements such as cameras, trackers and sensors are being integrated in smart pills, making them a key tool to assess the health of consumer from within the body.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/21712

In the near future, smart pills will gain grounds in diagnostics and health monitoring applications. These unique devices are being widely used in non-invasive examination of gastrointestinal diseases. Companies developing smart pills are extending their functions in assessment of health across a range of physiological metrics. With evolution in medical technology, the data procured by smart pills is becoming highly accurate and these pills are strengthening the patient adherence towards measuring medications.

Persistence Market Research's recently published report on the global smart pills market projects that the demand for these miniaturized devices will gain traction during the forecast period, 2017-2026. The report projects that by the end of 2026, more than US$ 3.1 Bn worth of smart pills will be sold globally. Over the forecast period, the global smart pills market is pegged to expand robustly at a CAGR of 14.5%. The study projects that the future prospects of smart pills will majorly revolve around their growing use as a device that can monitor daily medicine intake of consumers.

Company Profiles:
CapsoVision, Inc.
Given Imaging, Inc.
Medimetrics S.A. de C.V.
Olympus Corporation
Bio-Images Research Limited
Medtronic
Proteus digital Health
MediSafe
Boston Scientific Corporation
GE Healthcare
Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/21712

Drug Delivery Applications of Smart Pills to Gain Traction

The report estimates that in 2017, smart pills worth over US$ 300 Mn have been sold globally for their use in drug delivery applications. Increasing non-adherence of patients towards medication intake has driven the medical professionals such as doctors in compelling their patients to consume smart pills. Miniscule sensors embedded in smart pills are being used to detect the presence of elements in stomach, and this information is being transmitted to the patch worn by patients.

The procured data reveals the daily medicine intake of the patients and allows the doctors to facilitate effective drug delivery while monitoring the health of patients. The report also reveals that capsule endoscopy will be the leading application in the global smart pills market through 2026.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/21712

Esophagus to Represent Key Target Area for Positioning of Smart Pills

Through 2026, majority of medical professionals will allow the patients to consume smart pills and get them positioned in the esophagus. Effectiveness of smart pills in detecting the presence of different elements being consumed through food or medicine will continue to drive their positioning in the esophagus target area. By the end of 2026, more than US$ 1.2 Bn worth of smart pills to be sold in the global market will be used for targeting the esophagus.

The report has further revealed that the demand for smart pills is expected to be high North America and Europe. Robust healthcare infrastructure in the US is expected to drive the expansion of North America's smart pills market through 2026. The report also reveals that leading players in the global smart pills market are based in North America and several European countries.

Access Related Reports-

Bioinformatics Market: https://www.persistencemarketresearch.com/market-research/bioinformatics-market.asp

Balloon Infusers Market: https://www.persistencemarketresearch.com/market-research/balloon-infusers-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.